A Phase I Study of QLS12004 in Patients With Advanced Solid Tumors
Clinical trial NCT05829616 · UNKNOWN
Trial details
- NCT number
- NCT05829616
- Sponsor
- Qilu Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-17
- Primary completion
- 2024-05-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.